<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>URO NOTES</title>
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="by Jay Kim     template    template  mortality is ***% intraoperative early postoperative late postoperative bleeding pain  a    OSCE stations post prostatectomy incontinence - AUS complications, contraindications infertility guidelines functional urology questions autonomic dysreflexia, botox therapy indications/contraindications stone management in pregnancy postnatal hydro bosniak cyst nmibc and PCa screening SBK ">
    <link rel="stylesheet" href="theme.css">
    <style>
    
.normal_text {
font-family: Arial;
font-size: 11.0PT;
color: #000000;
line-height: 1.0;
direction: ltr;
}
h1 {
font-family: Arial;
font-size: 14.0PT;
font-weight: bold;
padding-top: 24.0PT;
padding-bottom: 6.0PT;
direction: ltr;
}
h2 {
font-family: Arial;
font-size: 11.0PT;
font-weight: bold;
padding-top: 18.0PT;
padding-bottom: 4.0PT;
direction: ltr;
}
h3 {
font-size: 12.0PT;
color: #ff00ff;
font-style: italic;
padding-top: 14.0PT;
padding-bottom: 4.0PT;
direction: ltr;
}
h4 {
font-size: 12.0PT;
font-weight: bold;
padding-top: 12.0PT;
padding-bottom: 2.0PT;
direction: ltr;
}
h5 {
font-size: 11.0PT;
font-weight: bold;
padding-top: 11.0PT;
padding-bottom: 2.0PT;
direction: ltr;
}
h6 {
font-size: 10.0PT;
font-weight: bold;
padding-top: 10.0PT;
padding-bottom: 2.0PT;
direction: ltr;
}
.title {
font-size: 36.0PT;
font-weight: bold;
padding-top: 24.0PT;
padding-bottom: 6.0PT;
direction: ltr;
}
.subtitle {
font-family: Georgia;
font-size: 24.0PT;
color: #666666;
font-style: italic;
padding-top: 18.0PT;
padding-bottom: 4.0PT;
direction: ltr;
}


    </style>
</head>
<body>
<header>
    <div class="hamburger-menu" onclick="toggleMenu()">
        <span></span>
        <span></span>
        <span></span>
    </div>
    <nav>
    <ul>
        <li><a href="index.html">URO NOTES</a></li>
    </ul>
    </nav>
</header>
<div class="content"clear: both; overflow: auto; ">
<div style="clear: both;">&nbsp;</div><br><div class="title" style='direction: ltr; '><span style=''>UROLOGY NOTES
</span></div><p class="normal_text" style='direction: ltr; '><span style=''>by Jay Kim
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><table><tr><td><p class="normal_text" style='direction: ltr; text-align: center; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; text-align: center; '><span style=''>template
</span></p><p class="normal_text" style='direction: ltr; text-align: center; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p></td><td><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><li><span style=''>template
</span></li></td></tr></table><p class="normal_text" style='direction: ltr; '><span style=''><strong>
</strong></span></p><p class="normal_text" style='direction: ltr; '><span style=''><strong>mortality is ***%
</strong></span></p><table><tr><td><p class="normal_text" style='direction: ltr; '><span style=''>intraoperative
</span></p></td><td><p class="normal_text" style='direction: ltr; '><span style=''>early postoperative
</span></p></td><td><p class="normal_text" style='direction: ltr; '><span style=''>late postoperative
</span></p></td></tr><tr><td><li><span style='font-size: 10.0PT; '>bleeding 
</span></li></td><td><li><span style='font-size: 10.0PT; '>pain
</span></li><p class="normal_text" style='direction: ltr; '><span style='font-size: 10.0PT; '><strong>
</strong></span></p></td><td><li><span style='font-size: 10.0PT; '>a
</span></li></td></tr></table><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><h1 style='direction: ltr; '><span style=''>Topics to Review
</span></h1><ul style="padding-left: 20.0px;"><li><span style=''>
</span></li></ul><h1 style='direction: ltr; '><span style=''>Quick Notes
</span></h1><p class="normal_text" style='direction: ltr; '><span style=''>OSCE stations
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>post prostatectomy incontinence - AUS complications, contraindications
</span></li><li><span style=''>infertility guidelines
</span></li><li><span style=''>functional urology questions
</span></li><li><span style=''>autonomic dysreflexia, botox therapy indications/contraindications
</span></li><li><span style=''>stone management in pregnancy
</span></li><li><span style=''>postnatal hydro
</span></li><li><span style=''>bosniak cyst
</span></li><li><span style=''>nmibc and PCa screening
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>SBK rounds
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>genetic predisposition to radiation - ATM gene
</span></li><li><span style=''>rectourethral fistula management
</span></li></ul><h1 style='direction: ltr; '><span style=''>Clinical Decision Making
</span></h1><p class="normal_text" style='direction: ltr; '><span style=''>HPI
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>pain
</span></li><li><span style=''>onset, duration, prior episodes, localization of pain (tenderness vs referred pain), severity, medications used to alleviate, hx of chronic pain
</span></li><li><span style=''>pain can be from distension from obstruction or inflammation of parenchyma in the GU organ
</span></li><li><span style=''>obstruction - colicky-type pain, intermittent pain, always moving to seek position for comfort
</span></li><li><span style=''>parenchyma - constant pain, lays still, seeking not to exacerbate pain with motion
</span></li><li><span style=''>referred pain or associated symptoms
</span></li><li><span style=''>e.g. paroxysmal N/V from celiac plexus visceral innervation in kidney presentations
</span></li><li><span style=''>e.g. testicular or labial pain can be from ipsilateral obstructing distal ureteral stone 
</span></li><li><span style=''>renal pain
</span></li><li><span style=''>ipsilateral CVA lateral to vertebral spine and inferior to 12th rib
</span></li><li><span style=''>ddx: MSK, intraperitoneal 
</span></li><li><span style=''>intraperitoneal tends to be more anterior, peritonitis associated with diaphragmatic irritation
</span></li><li><span style=''>ureteral pain
</span></li><li><span style=''>distension and hyperperistalsis can result in pain from ureteral spasm; convey through T11-L1 dorsal ganglia
</span></li><li><span style=''>referred pain to testicle/labia
</span></li><li><span style=''>irritative voiding symptoms at UVJ
</span></li><li><span style=''>bladder pain
</span></li><li><span style=''>suprapubic pain
</span></li><li><span style=''>cystitis worse with bladder distension; improves with voiding; sharp stabbing pain at end of urination
</span></li><li><span style=''>retention has profound desire to urinate without ability
</span></li><li><span style=''>prostatic pain
</span></li><li><span style=''>deep within pelvis; irritative voiding symptoms
</span></li><li><span style=''>ddx: rectal pain
</span></li><li><span style=''>penile pain
</span></li><li><span style=''>flaccid penis: ddx includes paraphimosis, ulcerative lesions, referred pain from cystitis/prostatitis
</span></li><li><span style=''>rigid penis: priapism, Peyronies
</span></li><li><span style=''>scrotal pain
</span></li><li><span style=''>skin - inflammation of scrotal skin 
</span></li><li><span style=''>internal - epididymo-orchitis, torsion
</span></li><li><span style=''>referred - kidney/ureter 
</span></li><li><span style=''>hematuria
</span></li><li><span style=''>most common cause of GH in age>50y is bladder cancer
</span></li><li><span style=''>presence of urologic cancer in up to 25% of patients
</span></li><li><span style=''>rule out pseudohematuria (urine appear red due to dehydration, from food/drugs) - obtain clean urine sample and microscopy for RBCs
</span></li><li><span style=''>stage of stream
</span></li><li><span style=''>initial - prostate/urethral
</span></li><li><span style=''>terminal - bladder neck irritation
</span></li><li><span style=''>entire stream - unknown
</span></li><li><span style=''>shape - vermiform (upper tract), cuboid (bladder)
</span></li><li><span style=''>LUTS
</span></li><li><span style=''>obstructive
</span></li><li><span style=''>urinary retention, incomplete urinary emptying, urinary frequency, intermittency, weak flow, straining (Crede voiding), postvoid dribbling (occurs due to escape of urine in urethra is not milked back; more shaking)
</span></li><li><span style=''>irritative
</span></li><li><span style=''>frequency (normal up to 5-6), urgency, dysuria, nocturia (normal up to 2)
</span></li><li><span style=''>daytime frequency without nocturia - ?psychogenic (anxiety)
</span></li><li><span style=''>nocturia without daytime frequency - nighttime polyuria
</span></li><li><span style=''>can be sign of occult bladder cancer
</span></li><li><span style=''>can be measured objectively by AUA and IPSS scores
</span></li><li><span style=''>incontinence
</span></li><li><span style=''>involuntary passage of urine
</span></li><li><span style=''>stress - due to increased abdominal pressure
</span></li><li><span style=''>urge - urine coincident with sensation of urinary urgency
</span></li><li><span style=''>mixed - both stress and urge
</span></li><li><span style=''>continuous - constant wetness independence of abdominal pressure or urge to urinate; ddx includes urinary fistula, ectopic ureter
</span></li><li><span style=''>urinary incontinence only during the day and not at night can be due to saccular upper pole moeity of ectopic ureter in the more dependent in supine position while sleeping
</span></li><li><span style=''>pseudoincontinence - perineal wetness without true urinary incontinence on exam; ddx: chronic vaginal discharge, retention of urine due to severe labial folds
</span></li><li><span style=''>overflow - intravesical pressure exceeds urethral outlet resistance; more likely to occur at night since guarding reflect is less effective
</span></li><li><span style=''>functional - incontinence due to limited mobility or access to toilet
</span></li><li><span style=''>enuresis - incontinence during sleep is normal up to 3y of age
</span></li><li><span style=''>15% in 5y of age, 1% in 15y of age
</span></li><li><span style=''>primary enuresis (always present) 6y needs evaluation for ectopic ureter in female patient
</span></li><li><span style=''>sexual dysfunction
</span></li><li><span style=''>erectile dysfunction
</span></li><li><span style=''>inability to attain or maintain penile erection sufficient for satisfactory intercourse
</span></li><li><span style=''>50% of men <40y
</span></li><li><span style=''>assess for situational ED, nocturnal tumesence, IIEF or SHIM to monitor erectile function, orgasmic function, sexual desire, intercourse, overall satisfaction
</span></li><li><span style=''>loss of libido
</span></li><li><span style=''>could be due to hypogonadism
</span></li><li><span style=''>amount of TT necessary for libido is usually less than full stimulation of prostate/SV therefore the ones with adequate ejaculatory volumes are unlikely to have hypogonadism severe to cause loss of libido
</span></li><li><span style=''>subjective measure - validated questionnaires include ADAM (Androgen Deficiency in Aging Questionnaire), Aging Male Survey, Massachusetts Male aging Study Questionnaire
</span></li><li><span style=''>Hypogonadism Related Symptom Scale may correlate better with hypogonadism
</span></li><li><span style=''>premature ejaculation
</span></li><li><span style=''>defined as <1 min if lifelong or <3min if acquired; inability to delay ejaculation with negative personal consequence
</span></li><li><span style=''>intravaginal ejaculatory latency time (IELT) median 5 min
</span></li><li><span style=''>anejaculation
</span></li><li><span style=''>hypogonadism vs drugs vs bladder neck/prostate surgery vs SNS blockade (RPLND)
</span></li><li><span style=''>anorgasmia - no euphoria associated with muscular contractions in genital regions and release of endorphins
</span></li><li><span style=''>e.g. impaired pudendal nerve function (DM2)
</span></li><li><span style=''>hematospermia
</span></li><li><span style=''>presence of blood in ejaculate
</span></li><li><span style=''>etiology: nonspecific inflammation of prostate or SVs; associated with ejaculation after long sexual abstinence
</span></li><li><span style=''>when to evaluate: persistent for several weeks with genital exam, DRE, PSA, cystoscopy and urine cytology to r/o GU TB or cancer
</span></li><li><span style=''>pneumaturia
</span></li><li><span style=''>passage of gas within urine
</span></li><li><span style=''>etiology: fistula with GI system (Crohn disease, intraabdo Sx, radiation), gas forming bacteria (severe UTI, immunocompromised status
</span></li><li><span style=''>urethral discharge
</span></li><li><span style=''>etiology: STI, urethral cancer (if hematuric)
</span></li><li><span style=''>fevers and chills
</span></li><li><span style=''>subjective vs objective
</span></li><li><span style=''>rigors/chills - ?bacteremia
</span></li><li><span style=''>constitutional symptoms - fevers, chills, night sweats, anorexia, weight loss, fatigue, lethargy
</span></li><li><span style=''>etiology: advanced inflammatory, infectious, malignant processes
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>medical history
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>performance status - ADLs (dressing, eating,a mbulating, toileting, hygiene) and instrumental ADLs (cleaning, maintaining a house, managing money, preparing meals, shopping, community participations)
</span></li><li><span style=''>ADLs are independent predictors of complications after PCNL
</span></li><li><span style=''>scales: ECOG score, Karnofsky performance status
</span></li><li><span style=''>PSHx - prev history may change approach (Hasson instead of Veress)
</span></li><li><span style=''>medications
</span></li><li><span style=''>can be associated urologic side effects
</span></li><li><span style=''>decreased libido (1)
</span></li><li><span style=''>HCTZ
</span></li><li><span style=''>erectile dysfunction (2)
</span></li><li><span style=''>propranolol, benzodiazepine 
</span></li><li><span style=''>ejaculatory dysfunction (2 classes)
</span></li><li><span style=''>alpha-blockers (3) - prazosin, tamsulosin, methyldopa
</span></li><li><span style=''>psychotropic (2) - phenothiazines, antidepressants
</span></li><li><span style=''>priapism (4)
</span></li><li><span style=''>phenothiazines, trazodone, hydralazine, prazosin
</span></li><li><span style=''>decreased spermatogenesis (3 classes)
</span></li><li><span style=''>chemo (1) - alkylating agents
</span></li><li><span style=''>abuse potential (3) - MJ, EtOH, nic
</span></li><li><span style=''>endocrine (2) - antiandrogens, prostaglandins
</span></li><li><span style=''>incontinence/impaired voiding (6)
</span></li><li><span style=''>histamine, vasopressin, furosemide, valproic acid, diazepam, baclofen
</span></li><li><span style=''>mostly muscle relaxants
</span></li><li><span style=''>urinary retention/obstructive pattern (5 classes)
</span></li><li><span style=''>anticholinergics (3) - diazepam, oxybutynin, flavoxate
</span></li><li><span style=''>CCB (1) - nifedipine
</span></li><li><span style=''>antiparkinson - carbidopa, levodopa
</span></li><li><span style=''>alpha-agonists (2) - pseudoephedrine, phenuylephrine
</span></li><li><span style=''>antihistamines (2) - loratadine, diphenhydramine
</span></li><li><span style=''>acute renal failure (3 classes)
</span></li><li><span style=''>antimicrobials&nbsp;&nbsp;(4) - aminoglycosides, PCN, cephalosporins, amphotericin
</span></li><li><span style=''>chemo (1) - cisplatin
</span></li><li><span style=''>NSAID
</span></li><li><span style=''>phenytoin
</span></li><li><span style=''>gynecomastia (5 classes)
</span></li><li><span style=''>antihypertensive - verapamil
</span></li><li><span style=''>cardiac drug - digoxin
</span></li><li><span style=''>GI drug (2) - cimetidine, metocloproamide
</span></li><li><span style=''>psychotropic - phenothiazines
</span></li><li><span style=''>TCAs (2) - imipramine, amitriptylin
</span></li><li><span style=''>social history - EtOH, smoking, ilicit drug use, sexual relations, domestic station, occupation, family history
</span></li><li><span style=''>review of systems
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>physical examination
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>vitals +/- distress
</span></li><li><span style=''>general appearance 
</span></li><li><span style=''>kidneys
</span></li><li><span style=''>usually not visible nor palpable except in very thin adults or small children
</span></li><li><span style=''>bimanual exam +/- transillumination (cyst glows, solid mass does not)
</span></li><li><span style=''>ausculation - turbulent vascular flow (e.g. RAS, renal AV fistula)
</span></li><li><span style=''>percussion - CVA tenderness
</span></li><li><span style=''>bladder
</span></li><li><span style=''>palpable only if distended above pelvis (>150 mL)
</span></li><li><span style=''>inspectable if >500mL
</span></li><li><span style=''>percussion - dull to resonant sound beyond bladder
</span></li><li><span style=''>bimanual exam - assess mobility of bladder (identify pT3 UCC disease = independent predictor!)
</span></li><li><span style=''>penis
</span></li><li><span style=''>inspection - hair distribution, lesions on skin, foreskin, Tanner staging, urethrald discharge, meatal location
</span></li><li><span style=''>palpation - retract foreskin, subcutaneous plaques, tenderness, spongiofibrosis
</span></li><li><span style=''>scrotum
</span></li><li><span style=''>inspection - lesions, erythema, necrosis
</span></li><li><span style=''>palpation - tenderness, crepitus, testicular size/orientation (normal is 6x4cm, firm, rubbery consistency ovoid surface), tenderness, paratesticular masses, vas deferens (al dente linguini), transillumination
</span></li><li><span style=''>special - cremasteric reflex (absence specific for torsion), orchidometer
</span></li><li><span style=''>DRE
</span></li><li><span style=''>size, tenderness, nodules
</span></li><li><span style=''>position: standing with waist bent 90 deg, lateral decubitus with flexed hips
</span></li><li><span style=''>normal: chestnut sized, soft
</span></li><li><span style=''>pelvic exam in female
</span></li><li><span style=''>position: dorsal lithotomy with stirrups, use chaperone
</span></li><li><span style=''>inspection: atrophic changes, erosions, masses, ulcers, discharge, urethra (prolapse, caruncle, hyperplasia, cyst)
</span></li><li><span style=''>palpation: urethra for discharge/mass (r/o diverticulum), bimanual exam (pelvic mass, tenderness)
</span></li><li><span style=''>special: SUI demonstration with full bladder; prolapse
</span></li><li><span style=''>neurologic exam
</span></li><li><span style=''>sensory dermatome 
</span></li><li><span style=''>bulbocavernous reflex
</span></li><li><span style=''>testes integrity of the S2-4
</span></li><li><span style=''>squeeze glans penis or clitoris or tug on Foley should elicit immediate contraction of anal sphincter muscles
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>investigations
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>urinalysis
</span></li><li><span style=''>gross examination, chemical analysis, microscopic analysis
</span></li><li><span style=''>male - midstream urine sample
</span></li><li><span style=''>avoids contamination; retraction of foreskin and cleansing of meatus
</span></li><li><span style=''>four aliquots
</span></li><li><span style=''>voided bladder 1 (VB1) - initial 5-10mL, urethral flora
</span></li><li><span style=''>voided bladder 2 (VB2) - midstream, bladder flora
</span></li><li><span style=''>expressed prostatic secretions (EPS) - post prostatic massage, prostatic flora
</span></li><li><span style=''>voided bladder 3 (VB3) - 2-3 mL after massage, prostatic flora
</span></li><li><span style=''>female - catheterized sample if rUTIs or abx resistant organisms
</span></li><li><span style=''>midstream possible if labia separated and cleansed
</span></li><li><span style=''>neonates/infants - plastic bag
</span></li><li><span style=''>gross exam
</span></li><li><span style=''>colour - normal is pale yellow due to pigment urochrome
</span></li><li><span style=''>colourless - overhydration
</span></li><li><span style=''>cloudy/milky (3) phosphaturia, chyluria, pyuria
</span></li><li><span style=''>red (7) - hematuria, hemogloinuria, anthocyanin (beets, blackberries), chronic lead/mercury poisoning, phenolpthalein (bowel evacuants), phenothiazines, rifampin
</span></li><li><span style=''>orange (3) - dehydration, pyridium, sulfasalazine
</span></li><li><span style=''>yellow (3) - normal, phenactein, riboflavin
</span></li><li><span style=''>green-blue (8)- biliverdin, incanuria (tryptophan metabolites), amitriptyline, indigo carmine, methylene blue, phenols (IV cimetidine, promethazine), resocinol, triamterene
</span></li><li><span style=''>brown (7) - bile, porphyria, aloe/fava beans/rhubarb, chloroquine/primaquine, furazolidone, metronidazole, nitrofuantoin
</span></li><li><span style=''>brown/black (7) - alcaptonuria, hemorrhage, melanin, tyrosinosis, cascara/senna, methocarbamol, methyldopa, sorbitol
</span></li><li><span style=''>turbidity
</span></li><li><span style=''>most common: phosphaturia 
</span></li><li><span style=''>benign process for excess phosphate crystals precipitate in alkaline urine
</span></li><li><span style=''>rule out: acetic acid can cause immediate clearing, micro analysis shows amorphous phosphate crystals
</span></li><li><span style=''>pyuria - WBC in UA, can indicate infxn
</span></li><li><span style=''>rare: chyluria, lipiduria, hyperoxaluria, hyperuricosuria
</span></li><li><span style=''>chemical analysis
</span></li><li><span style=''>interfered by pyridium since orange makes dipstick evaluation unreliable
</span></li><li><span style=''>needs horizontal orientation to avoid contaminating other sections
</span></li><li><span style=''>false negative in glucose and bilirubin if ↑ascorbic acid
</span></li><li><span style=''>false negative for protein in alkalinzed urine
</span></li><li><span style=''>specific gravity
</span></li><li><span style=''>usually reflects state of hydration and renal concentration ability
</span></li><li><span style=''>1.001-1.008 dilute
</span></li><li><span style=''>diuretics, diabetes inspidius, overhydration
</span></li><li><span style=''>1.020-1.035 concentrated
</span></li><li><span style=''>glycosuria, SIADH, dehydration
</span></li><li><span style=''>if >1.035&nbsp;&nbsp;IV contrast, dextran
</span></li><li><span style=''>1.010 can indicate chronic renal insufficiency
</span></li><li><span style=''>pH
</span></li><li><span style=''>ranges from 5-9; average 5.5-6.5; <5.5 is acidic, pH>6.5 is basic
</span></li><li><span style=''>urinary pH reflects serum pH usually
</span></li><li><span style=''>exception: RTA
</span></li><li><span style=''>type 1 and 2 shows serum low pH and high pH due to HCO3 loss into the urine
</span></li><li><span style=''>in severe metabolic acidosis, type 2 urine pH will become acidic but not type 1
</span></li><li><span style=''>test: inability to acidify urine below 5.5 is diagnostic of RTA
</span></li><li><span style=''>>7.5 indicates urease splitting organisms with presumed UTI
</span></li><li><span style=''>mech: ammonia to ammonium ions causing elevated pH; causes Ca-Mg-ammonium crystals
</span></li><li><span style=''>acidic in uric acid and cystine stones
</span></li><li><span style=''>blood/hematuria
</span></li><li><span style=''>normal <3 RBCs/hpf
</span></li><li><span style=''>dipstick is based on peroxidase-like activity of hemoglobin
</span></li><li><span style=''>positive by hemoglobinuria/myoglobinuria
</span></li><li><span style=''>microscopy to r/i hematuria
</span></li><li><span style=''>centrifuge to differentiate hemoglobinuria vs myoglobinuria
</span></li><li><span style=''>supernatant is pink for hemoglobinuria since free Hb binds to haptoglobin since water insoluble and high molecular weight (not true for myoglobin)
</span></li><li><span style=''>sensitivity >90%; specificity lower than microscopy
</span></li><li><span style=''>false positives (5) - hemoglobinuria, myoglobinuria, menstruating, severe dehydration, vigorous exercise
</span></li><li><span style=''>confirm with microscopy for hematuria workup
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><h1 style='direction: ltr; '><span style=''>Aging / Geriatric
</span></h1><p class="normal_text" style='direction: ltr; '><span style=''>defined as >60 as per WHO (pre young for uro)
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>physiology
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>renal
</span></li><li><span style=''>↓renal blood flow (RBF)
</span></li><li><span style=''>due to plaque formation and vascular disease
</span></li><li><span style=''>↓kidney mass
</span></li><li><span style=''>↓GFR
</span></li><li><span style=''>10cc/min per decade (50% at age 80)
</span></li><li><span style=''>↓renal concentrating ability
</span></li><li><span style=''>overestimation of GFR by serum Cr
</span></li><li><span style=''>lower Cr may be from ↓muscle mass, rather than true GFR
</span></li><li><span style=''>↓ADH
</span></li><li><span style=''>↑nocturia
</span></li><li><span style=''>bladder
</span></li><li><span style=''>↓ratio of smooth muscle:collagen
</span></li><li><span style=''>↓contractile strength
</span></li><li><span style=''>↑incontinence
</span></li><li><span style=''>↓compliance
</span></li><li><span style=''>↓sensation
</span></li><li><span style=''>↓striated muscle density in rhabdosphincter
</span></li><li><span style=''>↑incontinence
</span></li><li><span style=''>urethra
</span></li><li><span style=''>caruncle more prevalent in elderly women
</span></li><li><span style=''>other
</span></li><li><span style=''>cardiac → ↓compliance/elasticity→ ↓CO
</span></li><li><span style=''>respiratory → ∆chest wall elasticity/strength → ​​↑risk of PNA, PE, COPD
</span></li><li><span style=''>liver → ↓metabolic efficiency → ↓reserve for drug interactions
</span></li><li><span style=''>immune → ↑risk of UTI
</span></li><li><span style=''>vascular → ↓circulation to GU organs
</span></li><li><span style=''>GI → ↓bowel motility
</span></li><li><span style=''>endocrine → ↑DM2 risk → CKD and ED
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>GU malignancies
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>testis → lymphoma
</span></li><li><span style=''>prostate- → adenocarcinoma
</span></li><li><span style=''>PSA discontinued at age 70
</span></li><li><span style=''>use radiation
</span></li><li><span style=''>ADT increases risk of CV disease, osteoporosis
</span></li><li><span style=''>bladder cancer → TCC
</span></li><li><span style=''>median age >70y
</span></li><li><span style=''>BCG appears less effective in elderly
</span></li><li><span style=''>kidney cancer → RCC
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>functional assessment
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>ADLs + iADLs
</span></li><li><span style=''>mobility
</span></li><li><span style=''>Timed Up and Go Test (TUG)
</span></li><li><span style=''>cognition
</span></li><li><span style=''>MMSE
</span></li><li><span style=''>Mini-Cog
</span></li><li><span style=''>depression
</span></li><li><span style=''>Geriatric Depression Scale (GDS)
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>surgical assessment
</span></p><p class="normal_text" style='direction: ltr; '><img src="img/eb3f1c77bae08ed59744b6807f0e1cf333b20b1d.png" style="width: 401.4050311032548px; height: 325.97903173828036px; margin: 9.0PT 9.0PT 9.0PT 9.0PT; "><span style=''>
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>post-op elderly patients have 3.5x risk of mortality for wound infections
</span></li><li><span style=''>no difference between regional vs GA in mortality
</span></li><li><span style=''>hypothermia → increased risk for CV and VTE events
</span></li><li><span style=''>frailty scale
</span></li><li><span style=''>1-2 points = pre-frail; 3-5 points = frail
</span></li><li><span style=''>unintentional weight loss (>10lbs, 5% BW, in 1 year)
</span></li><li><span style=''>reduced grip strength
</span></li><li><span style=''>slowed gait speed/mobility
</span></li><li><span style=''>decreased level of activity
</span></li><li><span style=''>sense of easy exhaustion
</span></li><li><span style=''>delirium - 2-3x risk of mortality within year from surgery
</span></li><li><span style=''>DIMS criteria for diagnosis
</span></li><li><span style=''>risk factor: pain 
</span></li><li><span style=''>avoid sedatives, anticholinergics + opioids
</span></li><li><span style=''>tx: haloperidol 
</span></li><li><span style=''>no benzos or sedative hyponotics
</span></li><li><span style=''>pressure ulcers
</span></li><li><span style=''>Beers Criteria with urinary meds
</span></li></ul><p class="normal_text" style='direction: ltr; '><img src="img/0535bfd4933bf9c2f95f078d4f2393c0cc5b8ece.png" style="width: 1883.529px; height: 1457.6354999999999px; margin: 9.0PT 9.0PT 9.0PT 9.0PT; "><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><img src="img/92ce8363ef6df03c113606990699017aed951b08.png" style="width: 1905.5235px; height: 1567.608px; margin: 9.0PT 9.0PT 9.0PT 9.0PT; "><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><h1 style='direction: ltr; '><span style=''>On-Call Presentations
</span></h1><p class="normal_text" style='direction: ltr; '><span style=''>Urinary retention
</span></p><p class="normal_text" style='direction: ltr; '><span style='color: #1155cc; '><a href="https://intuitiveurology.com/images/pdf_uploads/chapter_summaries/basics_of_urology/instrumentation_cystoscopy.pdf" style="color: #1155cc; ">https://intuitiveurology.com/images/pdf_uploads/chapter_summaries/basics_of_urology/instrumentation_cystoscopy.pdf</a></span><span style=''>
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>difficult Foley catheter
</span></li><li><span style=''>DDx: by position
</span></li><li><span style=''>meatal stenosis, phimosis
</span></li><li><span style=''>urethral stricture, mass, false passage
</span></li><li><span style=''>BPH, bladder neck stenosis
</span></li><li><span style=''>type of catheter
</span></li><li><span style=''>silicone, size, 3-way, coude
</span></li><li><span style=''>types
</span></li><li><span style=''>blind try, ureteric catheter try, cysto
</span></li><li><span style=''>SP tube - indications
</span></li><li><span style=''>contraindications
</span></li><li><span style=''>if so, IR can put it i
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>Paraphimosis
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>series of events
</span></li><li><span style=''>manual reduction
</span></li><li><span style=''>dorsal slit
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>Hematuria
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>CBI conservative management
</span></li><li><span style=''>hyperbaric O2
</span></li><li><span style=''>intravesical therapy
</span></li><li><span style=''>supravesical diversion
</span></li><li><span style=''>cystectomy
</span></li><li><span style=''>hemorrhagic cystitis - definition is diffuse bleeding from bladder mucosa
</span></li><li><span style=''>AUA update 2025
</span></li></ul><p class="normal_text" style='direction: ltr; '><img src="img/bef5c58789ca267bdb22057e0135c00df684eae7.png" style="width: 556.360875px; height: 460.2824909638554px; margin: 9.0PT 9.0PT 9.0PT 9.0PT; "><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><img src="img/a2b83ae3ab3635e3e009ebe58b359843a998ca7d.png" style="width: 736.81575px; height: 812.79675px; margin: 9.0PT 9.0PT 9.0PT 9.0PT; "><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><img src="img/7f3903ef7fae13e0d9b9b2417d812a4a13f4573c.png" style="width: 575.4761858732678px; height: 598.2172865224859px; margin: 9.0PT 9.0PT 9.0PT 9.0PT; "><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style=''>viruses in immunosuppressed patients
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>BK virus - most common cause (mostly BMT)
</span></li><li><span style=''>adenovirus (type 11, 35) - most common in pediatric and renal transplant
</span></li><li><span style=''>
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>Hydronephrosis
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>PIUS or kidney preservation
</span></li><li><span style=''>stent vs neph tube vs NU tube
</span></li><li><span style=''>indications vs contraindications
</span></li><li><span style=''>post management
</span></li><li><span style=''>nephrostgram, RGP
</span></li><li><span style=''>changes
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>Priapism
</span></p><ul style="padding-left: 20.0px;"><li><span style=''>see priapism note
</span></li></ul><p class="normal_text" style='direction: ltr; '><span style=''>
</span></p><p class="normal_text" style='direction: ltr; '><span style='color: #1155cc; '><a href="https://docs.google.com/presentation/d/1cZvV-aCRQSuv5gD7V7NVWtnpqfxhFHrBNVLgol2IUB8/edit?usp=drive_link" style="color: #1155cc; ">PGY1 Orientation Slides</a></span><span style=''>
</span></p>
</div><footer>
    Created for free by
    <a href="https://gdocweb.com" target="_blank">gdocweb</a>. <br>
    Convert Google Docs files to full fledged websites <b>for free</b>.
</footer>
<script>
function toggleMenu() {
    var header = document.querySelector('header');
    header.classList.toggle('nav-active');
}

function toggleSubmenu(event, submenuId) {
    var submenu = document.getElementById(submenuId);
    var parentLi = submenu.parentElement;
    parentLi.classList.toggle('submenu-active');
    event.stopPropagation();
}

window.onclick = function(event) {
    var submenus = document.getElementsByClassName("submenu");
    for (var i = 0; i < submenus.length; i++) {
        var parentLi = submenus[i].parentElement;
        if (!parentLi.contains(event.target)) {
            parentLi.classList.remove('submenu-active');
        }
    }
}
</script>
</body>
</html>